New Cousteau-Linked...
Health Care: Drugs
ADVENTRX Pharmaceuticals Inc. (ANX: AMEX)
$0.51 -0.01 | -2.11%
06/04/12 - 03:14 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 0.00 | 488.96K | 300.00K | 500.00K |
| Cost of Sales | -11.15K | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 11.15K | 488.96K | 300.00K | 500.00K |
| Selling, General, and Administrative Expenses | 7.19M | 5.32M | 5.00M | 9.72M |
| Research & Development | 5.76M | 3.69M | 6.51M | 17.92M |
| Operating Income before D & A (EBITDA) | -12.94M | -8.52M | -11.21M | -27.14M |
| Depreciation & Amortization | 48.72K | 19.82K | 79.73K | 168.04K |
| Interest Income | 76.59K | 92.87K | 7.16K | 549.96K |
| Other Income - Net | -339.51K | -2.47K | -46.54K | 112.38K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -13.25M | -8.45M | -11.33M | -26.65M |
| Interest Expense | 11.01K | 1.63K | 0.00 | 0.00 |
| Pre-Tax Income | -13.26M | -8.45M | -11.33M | -26.65M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -13.26M | -8.45M | -11.33M | -26.65M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -13.26M | -8.45M | -11.33M | -26.65M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -13.26M | -8.45M | -11.33M | -26.65M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-13.26M | -8.45M | -11.33M | -26.65M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -13.26M | -14.09M | -16.19M | -26.65M |
| Basic EPS from Continuing Ops. | -0.47 | -1.07 | -3.50 | -7.50 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.47 | -1.07 | -3.50 | -7.50 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.47 | -1.07 | -3.50 | -7.50 |
| Basic Normalized Net Income/Share | -0.47 | -1.07 | -3.50 | -7.50 |
| EPS fr Continuing Ops. | -0.47 | -1.07 | -3.50 | -7.50 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.47 | -1.07 | -3.50 | -7.50 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.47 | -1.07 | -3.50 | -7.50 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.47 | -1.07 | -3.50 | -7.50 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ANX
- Portfolio NameUser Type
- Uservlady 1
- Usertesting
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Trades for Seco...
- UserDusty's Tracker
- UserDustel's Growth Stocks
- UserOwn
- UserASCO 2010 Part 2
- UserCDBrevard Portfolio 1
Latest ANX Headlines from TheStreet
- For Biotech, 'Fail' is Making a Big Comeback 03.12.12 | 08:03 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 11.11.11 | 08:11 am
- 5 Stocks Under $10 Setting Up to Trade Higher 09.15.11 | 01:09 pm
- 5 Stocks Setting Up to Break Out 09.09.11 | 03:09 pm
- ADVENTRX Stock Hits New 52-Week Low (ANX) 08.10.11 | 09:08 am
- Adventrx: FDA Rejects Lung Cancer Drug 08.10.11 | 07:08 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Sangamo Biosciences 07.22.11 | 05:07 am
- Biotech Stock Live Chat 07.15.11 | 12:07 pm
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
Press Releases for ANX
- ADVENTRX Pharmaceuticals To Sponsor & Present At The Martin Center's 2012 Sickle Cell Disease Conference - PR Newswire 04.16.12 | 08:04 am
- ADVENTRX Announces Establishment Of Regulatory Advisory Board - PR Newswire 04.09.12 | 08:04 am
- Vista Partners Updates Coverage On ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire 03.21.12 | 09:03 am
- ADVENTRX CEO Selected By Combined Health Agencies As A 2012 Health Hero - PR Newswire 03.15.12 | 08:03 am
- ADVENTRX Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 14 - PR Newswire 02.07.12 | 08:02 am
- Vista Partners Publishes February 2012 Newsletter - PR Newswire 02.02.12 | 09:02 am
- Vista Partners Updates Coverage On ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price - PR Newswire 12.15.11 | 09:12 am
- ADVENTRX Meets With FDA To Discuss Development Plans For ANX-188 - PR Newswire 12.01.11 | 08:12 am
- ADVENTRX Announces Closing Of Public Offering - PR Newswire 11.16.11 | 03:11 pm
- ADVENTRX Prices Public Offering Of Stock - PR Newswire 11.11.11 | 08:11 am
Partner Headlines for ANX
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 12.19.11 | 09:12 am
- Why CytRx Corporation Is Still A Big Biotech 'If' Play - Seeking Alpha 12.14.11 | 09:12 am
- Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets - NASDAQ 12.07.11 | 06:12 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 12.02.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Company News for August 11, 2011 - Corporate Summary - Zacks 08.11.11 | 10:08 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.21.11 | 09:07 am
- Adventrx Pharmaceuticals: Undervalued Based on Product Approval Potential - Seeking Alpha 07.21.11 | 08:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
